235 related articles for article (PubMed ID: 15950648)
1. Inhibin A and activin A may be used to predict pregnancy outcome in women with recurrent miscarriage.
Prakash A; Laird S; Tuckerman E; Li TC; Ledger WL
Fertil Steril; 2005 Jun; 83(6):1758-63. PubMed ID: 15950648
[TBL] [Abstract][Full Text] [Related]
2. First trimester levels of inhibins and activin A in normal and failing pregnancies.
Wallace EM; Marjono B; Tyzack K; Tong S
Clin Endocrinol (Oxf); 2004 Apr; 60(4):484-90. PubMed ID: 15049964
[TBL] [Abstract][Full Text] [Related]
3. Preliminary prospective study of the endocrinology of conception cycles and early pregnancy in women with antiphospholipid syndrome treated with low molecular weight heparin.
Prakash A; Laird S; Li TC; Ledger WL
Fertil Steril; 2006 Jan; 85(1):165-70. PubMed ID: 16412749
[TBL] [Abstract][Full Text] [Related]
4. A study of luteal phase expression of inhibin, activin, and follistatin subunits in the endometrium of women with recurrent miscarriage.
Prakash A; Li TC; Tuckerman E; Laird S; Wells M; Ledger WL
Fertil Steril; 2006 Dec; 86(6):1723-30. PubMed ID: 17074342
[TBL] [Abstract][Full Text] [Related]
5. Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia.
Davidson EJ; Riley SC; Roberts SA; Shearing CH; Groome NP; Martin CW
BJOG; 2003 Jan; 110(1):46-52. PubMed ID: 12504935
[TBL] [Abstract][Full Text] [Related]
6. Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia.
Spencer K; Cowans NJ; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Oct; 32(5):622-6. PubMed ID: 18816493
[TBL] [Abstract][Full Text] [Related]
7. Adhesion molecules, activin and inhibin--candidates for the biochemical prediction of hypertensive diseases in pregnancy?
Hanisch CG; Pfeiffer KA; Schlebusch H; Schmolling J
Arch Gynecol Obstet; 2004 Sep; 270(2):110-5. PubMed ID: 12898146
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of inhibin A, activin A and follistatin in missed and recurrent miscarriages.
Muttukrishna S; Jauniaux E; Greenwold N; McGarrigle H; Jivraj S; Carter S; Elgaddal S; Groome N; Regan L
Hum Reprod; 2002 Dec; 17(12):3072-8. PubMed ID: 12456605
[TBL] [Abstract][Full Text] [Related]
9. Uterine vein and maternal urinary levels of activin A and inhibin A in pre-eclampsia patients.
Muttukrishna S; Hyett J; Paine M; Moodley J; Groome N; Rodeck C
Clin Endocrinol (Oxf); 2006 Apr; 64(4):469-73. PubMed ID: 16584522
[TBL] [Abstract][Full Text] [Related]
10. Serum and urine inhibin A but not free activin A are endocrine biomarkers of severe pre-eclampsia.
Hamar BD; Buhimschi IA; Sfakianaki AK; Pettker CM; Magloire LK; Funai EF; Copel JA; Buhimschi CS
Am J Obstet Gynecol; 2006 Dec; 195(6):1636-45. PubMed ID: 16959203
[TBL] [Abstract][Full Text] [Related]
11. A combination treatment of prednisone, aspirin, folate, and progesterone in women with idiopathic recurrent miscarriage: a matched-pair study.
Tempfer CB; Kurz C; Bentz EK; Unfried G; Walch K; Czizek U; Huber JC
Fertil Steril; 2006 Jul; 86(1):145-8. PubMed ID: 16716321
[TBL] [Abstract][Full Text] [Related]
12. Maternal serum activin A and the prediction of intrauterine growth restriction.
Barkehall-Thomas A; Tong S; Baker LS; Edwards A; Wallace EM
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):97-101. PubMed ID: 16638029
[TBL] [Abstract][Full Text] [Related]
13. Circulating levels of inhibin A, inhibin B and activin A in normal and intrauterine growth restricted (IUGR) fetuses.
Morpurgo PS; Cetin I; Borgato S; Cortelazzi D; Nobile-Desantis MS; Vaghi I; Beck-Peccoz P
Eur J Obstet Gynecol Reprod Biol; 2004 Nov; 117(1):38-44. PubMed ID: 15474242
[TBL] [Abstract][Full Text] [Related]
14. Pre-eclampsia with fetal growth restriction: placental and serum activin A and inhibin A levels.
Florio P; Ciarmela P; Luisi S; Palumbo MA; Lambert-Messerlian G; Severi FM; Petraglia F
Gynecol Endocrinol; 2002 Oct; 16(5):365-72. PubMed ID: 12587530
[TBL] [Abstract][Full Text] [Related]
15. Measurement of inhibin A and inhibin pro-alphaC in early human pregnancy and their role in the prediction of pregnancy outcome in patients with recurrent pregnancy loss.
Al-Azemi M; Ledger WL; Diejomaoh M; Mousa M; Makhseed M; Omu A
Fertil Steril; 2003 Dec; 80(6):1473-9. PubMed ID: 14667886
[TBL] [Abstract][Full Text] [Related]
16. The addition of activin A and inhibin A measurement to uterine artery Doppler velocimetry to improve the early prediction of pre-eclampsia.
Florio P; Reis FM; Pezzani I; Luisi S; Severi FM; Petraglia F
Ultrasound Obstet Gynecol; 2003 Feb; 21(2):165-9. PubMed ID: 12601840
[TBL] [Abstract][Full Text] [Related]
17. Inhibin, activin, follistatin, activin receptors and beta-glycan gene expression in the villous tissue of miscarriage patients.
Muttukrishna S; Bearfield C; Johns J; Jauniaux E
Mol Hum Reprod; 2004 Nov; 10(11):793-8. PubMed ID: 15361555
[TBL] [Abstract][Full Text] [Related]
18. Midluteal serum progesterone concentration does not predict the outcome of pregnancy in women with unexplained recurrent miscarriage.
Yan J; Liu F; Yuan X; Saravelos SH; Cocksedge K; Li TC
Reprod Biomed Online; 2013 Feb; 26(2):138-41. PubMed ID: 23273755
[TBL] [Abstract][Full Text] [Related]
19. [Use of biochemical markers to predict the outcome of pregnancies conceived by in vitro fertilization].
Hauzman E; Murber A; Fancsovits P; Papp Z; Urbancsek J
Orv Hetil; 2006 Jul; 147(30):1409-20. PubMed ID: 16977779
[TBL] [Abstract][Full Text] [Related]
20. Inhibins and activins in human fetal abnormalities.
Lambert-Messerlian GM; Pinar H; Laprade E; Tantravahi U; Schneyer A; Canick JA
Mol Cell Endocrinol; 2004 Oct; 225(1-2):101-8. PubMed ID: 15451574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
